STOCK TITAN

SOPHiA GENETICS (SOPH) CPO sells shares to cover RSU tax withholding

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

SOPHiA GENETICS SA Chief People Officer Manuela Valente sold 4,241 Ordinary Shares in an open-market transaction. The shares were sold at a weighted average price of $5.053 per share to cover tax withholding obligations tied to restricted stock units vesting on July 2 and July 3, 2026, under a pre-established Rule 10b5-1(c) trading plan. After this sale, she directly holds 210,450 Ordinary Shares.

Positive

  • None.

Negative

  • None.
Insider Valente Manuela
Role Chief People Officer
Sold 4,241 shs ($21K)
Type Security Shares Price Value
Sale Ordinary Shares 4,241 $5.053 $21K
Holdings After Transaction: Ordinary Shares — 210,450 shares (Direct, null)
Footnotes (1)
  1. Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on July 2, 2026 and July 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.95 to $5.34, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Shares sold 4,241 shares Ordinary Shares sold on July 6, 2026
Weighted average sale price $5.053 per share Open-market sale to satisfy tax withholding
Post-transaction holdings 210,450 shares Ordinary Shares directly held after the sale
Sale price range $4.95 to $5.34 Range of individual trade prices for the reported sale
RSU vesting dates July 2 and July 3, 2026 Tax obligation arose from RSU vesting on these dates
Rule 10b5-1(c) trading plan regulatory
"These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person"
A Rule 10b5-1(c) trading plan is a legally defined, pre-set schedule that lets company insiders automatically buy or sell stock at specified times or under set formulas when they are not in possession of undisclosed, sensitive information. Think of it like an automatic payment plan for trades: because the instructions are written in advance, trades under the plan help protect insiders from allegations of trading on secret information and give investors clearer expectations about when insiders will transact, which can affect liquidity and perceived transparency.
restricted stock units financial
"tax withholding obligations arising in connection with the vesting of restricted stock units on July 2, 2026 and July 3, 2026"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open market financial
"Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations"
An open market is a system where buying and selling of goods, services, or financial assets happen freely without restrictions or special controls. For investors, it means they can trade assets easily and quickly, which helps determine fair prices based on supply and demand. This environment encourages transparency and competition, making it easier to buy or sell with confidence.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did SOPHiA GENETICS (SOPH) report for Manuela Valente?

SOPHiA GENETICS reported that Chief People Officer Manuela Valente sold 4,241 Ordinary Shares. The sale was an open-market transaction executed at a weighted average price of $5.053 per share to satisfy tax withholding obligations related to restricted stock unit vesting.

Why did Manuela Valente sell SOPHiA GENETICS (SOPH) shares?

She sold the shares to cover tax withholding obligations from restricted stock units that vested on July 2 and July 3, 2026. Such transactions are typically mechanical and linked to compensation rather than a discretionary decision to reduce ownership in the company.

How many SOPHiA GENETICS (SOPH) shares does Manuela Valente hold after the sale?

After the reported sale, Manuela Valente directly holds 210,450 Ordinary Shares. This remaining stake provides context that the 4,241 shares sold represent a small portion of her overall position in SOPHiA GENETICS SA based on this filing.

At what prices were Manuela Valente’s SOPHiA GENETICS (SOPH) shares sold?

The filing reports a weighted average sale price of $5.053 per share. The individual trades occurred across multiple transactions at prices ranging from $4.95 to $5.34 per share, inclusive, as disclosed in the footnotes to the Form 4.

Was the SOPHiA GENETICS (SOPH) insider sale made under a Rule 10b5-1 trading plan?

Yes. The filing states the sales were executed under a pre-established Rule 10b5-1(c) trading plan. This indicates the transactions were pre-planned and not discretionary, reducing the informational significance of their timing for investors reviewing insider activity.

Are Manuela Valente’s SOPHiA GENETICS (SOPH) share sales discretionary trades?

The filing specifies that these sales do not represent discretionary trades. They were effected pursuant to a pre-established Rule 10b5-1(c) trading plan and were intended to satisfy tax withholding obligations arising from the vesting of restricted stock units.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Valente Manuela

(Last)(First)(Middle)
C/O SOPHIA GENETICS SA
LA PIECE 12

(Street)
ROLLE1180

(City)(State)(Zip)

SWITZERLAND

(Country)
2. Issuer Name and Ticker or Trading Symbol
SOPHiA GENETICS SA [ SOPH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief People Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/06/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares07/06/2026S4,241(1)D$5.053(2)210,450D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on July 2, 2026 and July 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.95 to $5.34, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Remarks:
/s/ Elimara Brunetto as Attorney-in-fact for Manuela Valente07/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)